View on market: Volatility persists, eagerly searching for growth

Asian markets began the week on a weak note, extending a seven-day losing streak as concerns grew following soft US jobs data. This led to a renewed belief that the US Federal Reserve might consider cutting interest rates. Japanese stocks saw sharp declines, while South Korean markets remained mixed due to uncertainty around tax changes. Australian stocks slipped slightly, while Hong Kong futures showed some recovery. In Europe, stock futures were slightly higher, signaling a positive start to the trading day. This followed a week of global volatility and cautious optimism from investors. US markets had ended the previous week lower after disappointing job growth data and a rise in unemployment. Sentiment was further shaken when the US President announced new trade tariffs, which weighed heavily on stocks, especially in the technology sector. Indian markets also ended the week in the red, facing ongoing pressure from trade tensions with the US and continued selling by foreign investors.

Key Quarterly Results for Today:

ABCAPITAL, ABVL, ACEENGITEC, AGVENTURES, APTECHT, ARFIN, ATHERENERG, AUROPHARMA, BIRLANU, BLSE, BOSCHLTD, CRYSTAL, DEEPINDS, DELTACORP, DLF, ENRIN, EIHAHOTELS, ESCORTS, EVERESTIND, GPTINFRA, INOXINDIA, MARICO, META, SHREECEM, STEELXIND, SVGLOBAL, TATAINVEST, TFCILTD, TRITURBINE, UNICHEMLAB.

Economic Calendar:

• USD: Import and Export Data on 05^th August 2025.
• IND: S&P Global Services PMI (July) on 04^th August 2025.
• USD: Initial and Continuing Jobless Claim Data on 07^th August 2025.
• IND: Monetary Policy on 06^th August 2025.

IPO Watch:

Company	Open	Close	Price (Rs/-)	View
Highway Infra Ltd.	05th Aug	07th Aug	65-70	Under Review
Knowledge REIT	05th Aug	07th Aug	95-100	Under Review
JSW Cement Ltd.	07th Aug	11th Aug	139-147	Under Review

 

Brokerage Radar:

MACQUARIE ON ITC:

Maintain Outperform with TP of Rs 500, Inline Q1; Healthy cigarette volumes; paper weak, 6.5% cigarette volume growth and mix improvement partly offsetting leaf tobacco inflation, ITC sees signs of urban recovery in FMCG and saw correction in leaf tobacco costs in current crop cycle.

CITI ON DR REDDY:

Maintain Sell with TP of Rs 990, Competition Heating up in Canada Semaglutide; Taro Files for Generic, Expect More Filings in Coming Months, Maintain cautious stance on the Canada Semaglutide opportunity for Dr Reddy’s, Believe street expectations may need to be tempered.

UBS ON POWER GRID:

Maintain Sell with TP of Rs 300, Capitalization timelines still not impressive, Capex momentum evident, but overhang of project delays continues, Right of way still a challenge; Work in hand at elevated levels, Momentum in TBCB awarding could continue.

JEFFERIES ON ADANI POWER:

Maintain Buy with TP of Rs 690, Execution on Track, Q1 capacity was 17.6 GW and plan is intact to raise capacity by 1.7x to 30.7 GW by 2030, 600 MW Vidarbha acquisition has been completed in July 2025, Close co-ordination with BHEL for equipment delivery and in-house EPC are ensuring capex is on schedule.

International Markets:

U.S & Europe:

*As per 04^th August.

Asian markets:

Particulars	04th  Aug	Chg.	Chg.(%)
GIFT Nifty	24,688.50	74.90	0.30
Nikkei	40,116.00	-683.60	-1.68
Straits Times	4,184.95	31.12	0.75
Hang Seng	24,509.00	1.19	00
Shanghai	3,562.66	2.71	0.08

Stocks strong on Chart:

Commodities & Currency:

FIIs & DIIs:

News Updates:

Source: Moneycontrol, Bloomberg Quint, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 214 

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Vindhyachal Prasad, Elite Wealth Limited, vindhyachal@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

• all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
• No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale. Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. Reports
2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

• EWL or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
• EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

2. 2. Compensation

• • EWL or its associates have not received any compensation from the subject company in the past twelve months;
  • EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

• EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
• EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
• EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research

3. In respect of Public Appearances

• EWL or its associates have not received any compensation from the subject company in the past twelve months;
• The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL